Gaois

Search direction

Search mode

Filter results

Collections

767 results in 62 documents

  1. #641731

    Is é an t-urraitheoir, nó ionadaí de chuid an urraitheora, a shíneoidh an t-iarratas.

    The application shall be signed by the sponsor or a representative of the sponsor.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  2. #1890920

    ciallaíonn “urratheoir” urraitheoir mar a shainmhínítear é i bpointe (e) d’Airteagal 2 de Threoir 2001/20/CE;

    sponsor’ means sponsor as defined in point (e) of Article 2 of Directive 2001/20/EC;

    Regulation (EU) 2020/1043 of the European Parliament and of the Council of 15 July 2020 on the conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease (COVID-19)

  3. #352622

    urraitheoir (óstach, cuideachta, eagraíocht), sonraigh le do thoil

    by a sponsor (host, company, organisation), please specify

    Regulation (EC) No 810/2009 of the European Parliament and of the Council of 13 July 2009 establishing a Community Code on Visas

  4. #583177

    Chuige sin, ba cheart don tionscnóir nó don urraitheoir leas suntasach a choinneáil sna sócmhainní foluiteacha.

    To achieve this, the originator or sponsor should retain a significant interest in the underlying assets.

    Regulation (EU) No 575/2013 of the European Parliament and of the Council of 26 June 2013 on prudential requirements for credit institutions and investment firms and amending Regulation (EU) No 648/2012 Text with EEA relevance

  5. #586989

    Institiúidí tionscnóra agus institiúidí is urraitheoirí

    Originator and sponsor institutions

    Regulation (EU) No 575/2013 of the European Parliament and of the Council of 26 June 2013 on prudential requirements for credit institutions and investment firms and amending Regulation (EU) No 648/2012 Text with EEA relevance

  6. #589172

    CEANGLAIS LE HAGHAIDH INSTITIÚIDÍ IS URRAITHEOIRÍ AGUS INSTITIÚIDÍ TIONSCNÓRA

    REQUIREMENTS FOR SPONSOR AND ORIGINATOR INSTITUTIONS

    Regulation (EU) No 575/2013 of the European Parliament and of the Council of 26 June 2013 on prudential requirements for credit institutions and investment firms and amending Regulation (EU) No 648/2012 Text with EEA relevance

  7. #589189

    na ceanglais in Airteagal 408- agus in Airteagal 409 a bhfuil feidhm acu maidir le hinstitiúidí is urraitheoirí agus institiúidí tionscóra.

    the requirements in Articles 408 and 409 applying to sponsor and originator institutions.

    Regulation (EU) No 575/2013 of the European Parliament and of the Council of 26 June 2013 on prudential requirements for credit institutions and investment firms and amending Regulation (EU) No 648/2012 Text with EEA relevance

  8. #640619

    Ba cheart go mbeadh deis ag an urraitheoir an t-iarratas ar údarú do thriail chliniciúil a tharraingt siar.

    The sponsor should be allowed to withdraw the application for authorisation of a clinical trial.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  9. #640854

    Molfaidh an t-urraitheoir ceann de na Ballstáit lena mbaineann mar Bhallstát tuairiscithe.

    The sponsor shall propose one of the Member States concerned as reporting Member State.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  10. #640875

    Cibé an triail chliniciúil idirghabhála ísle í an triail chliniciúil, i gcás ina maíonn an t-urraitheoir amhlaidh.

    Whether the clinical trial is a low-intervention clinical trial, where claimed by the sponsor;

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  11. #640975

    Féadfaidh an t-urraitheoir an t-iarratas a tharraingt siar tráth ar bith go dtí an dáta tuairiscithe.

    The sponsor may withdraw the application at any time until the reporting date.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  12. #641114

    urraitheoir, imscrúdaitheoirí, daoine is ábhar ionchasacha, daoine is ábhar, agus suíomhanna um thrialacha cliniciúla;

    the sponsor, investigators, potential subjects, subjects, and clinical trial sites;

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  13. #641282

    Stopadh sealadach nó foirceannadh luath arna ndéanamh ag an urraitheoir ar mhaithe le sábháilteacht na ndaoine is ábhar

    Temporary halt or early termination by the sponsor for reasons of subject safety

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  14. #641298

    Tuairisciú ón imscrúdaitheoir chuig an urraitheoir maidir le teagmhais dhíobhálacha agus teagmhais dhíobhálacha thromchúiseacha

    Reporting of adverse events and serious adverse events by the investigator to the sponsor

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  15. #641304

    Coinneoidh an t-urraitheoir taifid mhionsonraithe de gach teagmhas díobhálach a thuairisceoidh an t-imscrúdaitheoir dó.

    The sponsor shall keep detailed records of all adverse events reported to it by the investigator.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  16. #641307

    Tuairisciú maidir le frithghníomhartha díobhálacha tromchúiseacha neamhthuartha amhrasta ón urraitheoir chuig an nGníomhaireacht

    Reporting of suspected unexpected serious adverse reactions by the sponsor to the Agency

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  17. #641311

    an t-urraitheoir sin; nó

    by that sponsor, or

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  18. #641312

    ag urraitheoir eile ar cuid de mháthairchuideachta chéanna urraitheoir na trialach cliniciúla nó, más urraitheoir é a fhorbraíonn táirge íocshláinte, ar bhonn comhaontaithe fhoirmiúil, i gcomhar le hurraitheoir na trialach cliniciúla.

    by another sponsor who is either part of the same parent company as the sponsor of the clinical trial, or who develops a medicinal product jointly, on the basis of a formal agreement, with the sponsor of the clinical trial.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  19. #641323

    Tuairisciú bliantúil ón urraitheoir chuig an nGníomhaireacht

    Annual reporting by the sponsor to the Agency

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  20. #641347

    STIÚRADH TRIALACH CLINICIÚLA, AN MHAOIRSEACHT A DHÉANFAIDH AN T-URRAITHEOIR, OILIÚINT AGUS TAITHÍ, TÁIRGÍ ÍOCSHLÁINTE CÚNTA

    CONDUCT OF A CLINICAL TRIAL, SUPERVISION BY THE SPONSOR, TRAINING AND EXPERIENCE, AUXILIARY MEDICINAL PRODUCTS

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  21. #641391

    Soláthróidh an t-urraitheoir bróisiúr an imscrúdaitheora don imscrúdaitheoir.

    The sponsor shall provide the investigator with the investigator's brochure.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  22. #641399

    Coinneoidh an t-urraitheoir agus an t-imscrúdaitheoir máistirchomhad trialach cliniciúla.

    The sponsor and the investigator shall keep a clinical trial master file.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  23. #641410

    Ceapfaidh an t-urraitheoir daoine aonair laistigh dá eagraíocht féin le bheith freagrach as na cartlanna.

    The sponsor shall appoint individuals within its organisation to be responsible for archives.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  24. #641488

    URRAITHEOIR AGUS IMSCRÚDAITHEOIR

    SPONSOR AND INVESTIGATOR

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  25. #641490

    Urraitheoir

    Sponsor

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  26. #641494

    Féadfaidh an duine céanna a bheith ina imscrúdaitheoir agus ina urraitheoir.

    The investigator and the sponsor may be the same person.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  27. #641500

    urraitheoir atá freagrach as comhlíonadh oibleagáidí urraitheora sna nósanna imeachta maidir le húdarú atá leagtha amach i gCaibidil II agus i gCaibidil III;

    a sponsor responsible for compliance with the obligations of a sponsor in the authorisation procedures set out in Chapters II and III;

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  28. #641502

    urraitheoir atá freagrach as na bearta arna nglacadh i gcomhréir hAirteagal 77 a chur chun feidhme.

    a sponsor responsible for implementing the measures taken in accordance with Article 77.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  29. #641508

    Ionadaí dlíthiúil an urraitheora san Aontas

    Legal representative of the sponsor in the Union

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  30. #641509

    I gcás nach mbeidh urraitheoir trialach cliniciúla bunaithe san Aontas, áiritheoidh an t-urraitheoir go mbeidh duine nádúrtha nó dlítheanach bunaithe san Aontas mar a ionadaí dlíthiúil.

    Where the sponsor of a clinical trial is not established in the Union, that sponsor shall ensure that a natural or legal person is established in the Union as its legal representative.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  31. #641511

    Measfar aon chumarsáid leis an ionadaí dlíthiúil sin mar chumarsáid leis an urraitheoir.

    Any communication to that legal representative shall be deemed to be a communication to the sponsor.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  32. #641516

    Ní dhéanfaidh an Chaibidil seo difear do dhliteanas sibhialta ná coiriúil an urraitheora, an imscrúdaitheora, nó aon duine a dtarmligfidh an t-urraitheoir cúram chuige.

    This Chapter shall not affect the civil and criminal liability of the sponsor, investigator, or persons to whom the sponsor has delegated tasks.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  33. #641531

    a cheangal ar an urraitheoir aon ghné den triail chliniciúil a mhodhnú.

    require the sponsor to modify any aspect of the clinical trial.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  34. #641728

    Déanfaidh an t-urraitheoir, i gcás inarb iomchuí, tagairt d'aon iarratais roimhe seo.

    The sponsor shall, where appropriate, refer to any previous applications.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  35. #641729

    Más urraitheoir eile a chuir na hiarratais sin isteach, cuirfear an comhaontú i scríbhinn ón urraitheoir sin isteach freisin.

    If these applications have been submitted by another sponsor, the written agreement from that sponsor shall be submitted.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  36. #641732

    Dearbhóidh an síniú go bhfuil an t-urraitheoir deimhin den méid seo a leanas:

    This signature confirms that the sponsor is satisfied that:

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  37. #641820

    teagmhais dhíobhálacha thromchúiseacha nach gá don imscrúdaitheoir a thuairisciú láithreach don urraitheoir.

    serious adverse events which do not require immediate reporting by the investigator to the sponsor.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  38. #641824

    tuairisciú frithghníomhartha díobhálacha tromchúiseacha neamhthuartha amhrasta ag an urraitheoir chuig bunachar sonraí Eudravigilance;

    reporting of suspected unexpected serious adverse reactions by the sponsor to the Eudravigilance database;

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  39. #641959

    Cuirfear isteach tuairisc ar aon chomhaontú eile idir an t-urraitheoir agus an láthair.

    Description of any other agreement between the sponsor and the site shall be submitted.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  40. #641968

    Dearbhófar leis an síniú sin gur deimhin leis an urraitheoir an méid seo a leanas:

    This signature shall confirm that the sponsor is satisfied that:

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  41. #641998

    TUAIRISCIÚ ÓN IMSCRÚDAITHEOIR CHUIG AN URRAITHEOIR MAIDIR LE TEAGMHAIS DHÍOBHÁLACHA THROMCHÚISEACHA

    REPORTING OF SERIOUS ADVERSE EVENTS BY THE INVESTIGATOR TO THE SPONSOR

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  42. #642005

    Ní dhéanfaidh an t-urraitheoir an measúnú ar chúisíocht a íosghrádú.

    The causality assessment given by the investigator shall not be downgraded by the sponsor.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  43. #642006

    Mura n-aontóidh an t-urraitheoir le measúnú an imscrúdaitheora ar an gcúisíocht, cuirfear tuairimí an imscrúdaitheora agus an urraitheora araon ar fáil sa tuarascáil.

    If the sponsor disagrees with the investigator's causality assessment, the opinion of both the investigator and the sponsor shall be provided with the report.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  44. #642009

    Leagfaidh an t-urraitheoir amach intuarthacht frithghnímh dhíobhálaigh san FTS.

    The expectedness of an adverse reaction shall be set out by the sponsor in the RSI.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  45. #642022

    uimhir staidéir urraitheora;

    a sponsor study number;

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  46. #642040

    Cuirfidh an t-urraitheoir tuarascáil iomlánaithe isteach laistigh d'ocht lá breise.

    The sponsor shall submit a completed report within an additional eight days.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  47. #642051

    TUAIRISCIÚ BLIANTÚIL ÓN URRAITHEOIR MAIDIR LE SÁBHÁILTEACHT

    ANNUAL SAFETY REPORTING BY THE SPONSOR

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  48. #642063

    Sonraí an urraitheora (lena n-áirítear pointí teagmhála eolaíocha agus poiblí);

    Sponsor details (including scientific and public contact points);.

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  49. #642097

    Ainm agus sonraí teagmhála an urraitheora;

    Name and contact details of the sponsor;

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

  50. #642147

    cód tagartha trialach cliniciúla lenar féidir láthair na trialach, an t-imscrúdaitheoir, an t-urraitheoir agus an duine is ábhar a aithint.

    clinical trial reference code allowing identification of the clinical trial site, investigator, sponsor and subject;

    Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance